Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03224520 · ClinicalTrials.gov registry record · NA
Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 1,487
- Enrollment target
NCT03224520: Completed NA study, sponsored by University of Massachusetts, Worcester.
NCT03224520 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 1,487 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03224520, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,487 participants
- Enrollment target
Study Summary
The research study, "Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions" will test two smoker-driven, social marketing innovations to recruit and engage smokers in Decide2Quit.org (Decide2Quit), which is an evidence-based, effective "Digital Intervention for Smoking Cessation".
Primary Outcome
Smoking cessation measured by the 7-day point prevalence question: Six month, 7-day point prevalence : Do you currently smoke cigarettes (smoked even 1 puff in the last 7 days)? * Yes * No * Don't know/not sure * Refused
Interventions
- BEHAVIORAL Recommender CTHC
- BEHAVIORAL Standard CTHC
- OTHER Peer Recruitment
- OTHER Standard Online Recruitment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,487 participants |
| Start Date | 2017-12-20 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
What the finished NCT03224520 record still lists
NCT03224520 is an interventional study that assigns participants to a tested intervention. Its 1,487 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 4 interventions - of which Recommender CTHC is the first listed.
NCT03224520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03224520 about?
NCT03224520 is a clinical study titled "Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions". The research study, "Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions" will test two smoker-driven, social marketing innovations to recruit and engage smokers in Decide2Quit.org (Decide2Quit), which is an evidence-based, effective "Digital Intervention for Smo...
What is the current status of trial NCT03224520?
This trial is currently completed. It is a NA study. The enrollment target is 1,487 participants. The study started on 2017-12-20. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03224520?
The interventions under investigation include: Recommender CTHC (BEHAVIORAL), Standard CTHC (BEHAVIORAL), Peer Recruitment (OTHER), Standard Online Recruitment (OTHER).
Who is sponsoring clinical trial NCT03224520?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03224520's enrollment target sits among peer trials
1,487 68th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI